Cytokinetics, Incorporated Forecast, price target & analysts
Cytokinetics, Incorporated Target price 2026 - Analyst rating & recommendation
Cytokinetics, Incorporated Classifications & Recommendation
Cytokinetics, Incorporated Price Target
| Target Price | $110.16 |
| Price | $63.92 |
| Potential | |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Cytokinetics, Incorporated 2027 . The average Cytokinetics, Incorporated target price is $110.16. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 28 analysts: 25 Analysts recommend Cytokinetics, Incorporated to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Cytokinetics, Incorporated stock has an average upside potential 2027 of . Most analysts recommend the Cytokinetics, Incorporated stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
24 Analysts have issued a sales forecast Cytokinetics, Incorporated 2026 . The average Cytokinetics, Incorporated sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
10 Analysts have issued an Cytokinetics, Incorporated EBITDA forecast 2026. The average Cytokinetics, Incorporated EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
24 Cytokinetics, Incorporated Analysts have issued a net profit forecast 2026. The average Cytokinetics, Incorporated net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
24 Analysts have issued a Cytokinetics, Incorporated forecast for earnings per share. The average Cytokinetics, Incorporated EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Cytokinetics, Incorporated...
Current Cytokinetics, Incorporated Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
